Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison

The Lancet Neurology

Volumn 8, Issue 3, 2009, Pages 235-243

  Luengo Fernandez, Ramon ^a   Gray, Alastair M ^a   Rothwell, Peter M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; RISK REDUCTION; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; COMMUNITY HEALTH PLANNING; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; TIME FACTORS;

EID: 60049092642     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70019-5     Document Type: Article

References (30)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., and Murray C.J.L. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367 (2006) 1747-1757
2. Wolfe C.D. The impact of stroke. Br Med Bull 56 (2004) 275-286
3. Luengo-Fernandez R., Leal J., Gray A., Petersen S., and Rayner M. Cost of cardiovascular diseases in the United Kingdom. Heart 92 (2006) 1384-1389
4. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
5. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
6. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342 (1993) 1255-1262
7. Heart Protection Study Collaborative Group. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20536 individuals. Lancet 365 (2005) 1779-1785
8. Rothwell P.M., Eliasziw M., Gutnikov S.A., Warlow C.P., and Barnett H.J.M. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 (2004) 915-924
9. Hackam D.G., and Spence J.D. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke 38 (2007) 1881-1885
10. Rothwell P.M., Giles M.F., Flossmann E., et al. A simple score (ABCD) to identify individuals at high early risk of stroke after a transient ischaemic attack. Lancet 366 (2005) 29-36
11. Johnston S.C., Rothwell P.M., Nguyen-Huynh M.N., et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369 (2007) 283-292
12. Rothwell P.M., Buchan A., and Johnston S.C. Recent advances in the management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 5 (2006) 323-331
13. Luengo-Fernandez R., Gray A., and Rothwell P.M. Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom. Stroke 37 (2006) 2579-2587
14. National Audit Office. Reducing brain damage: faster access to better stroke care (2005), The Stationery Office, London
15. Rothwell P.M., Giles M.F., Chandratheva A., et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
16. Rothwell P.M., Coull A.J., Silver L.E., Fairhead J.F., Giles M.F., and Lovelock C.E. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366 (2005) 1773-1783
17. Lavallée P.C., Meseguer E., Abboud H., et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 6 (2007) 953-960
18. van Swieten J.C., Koudstaal P.J., Visser M.C., Schouten H.J., and van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988) 604-607
19. Lyden P., Brott T., Tilley B., et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke 25 (1994) 2220-2226
20. Coull A.J., Silver L.E., Bull L.M., Giles M.F., and Rothwell P.M. Direct assessment of completeness of ascertainment in a stroke incidence study. Stroke 35 (2004) 2041-2047
21. Department of Health. NHS reference costs 2005-06. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_062884 (accessed Dec 11, 2008).
22. National Health Service. Annual financial returns of NHS trusts, 2003-2004 (2005), NHS Executive, Leeds
23. Briggs A., and Gray A. The distribution of healthcare costs and their statistical analysis for economic evaluation. J Health Serv Res Policy 3 (1998) 233-245
24. Manning W.G., and Mullahy J. Estimating log models: to transform or not to transform?. J Health Econ 20 (2001) 461-494
25. Rothwell P.M. External validity of randomised controlled trials: to whom do the results of this trial apply?. Lancet 365 (2005) 82-93
26. Patel A., Knapp M., Evans A., Perez I., and Kalra L. Training care givers of stroke patients: Economic evaluation. BMJ 328 (2004) 1102-1104
27. Dewey H.M., Thrift A.G., Mihalopoulos C., Carter R., Macdonell R.A., and McNeil J.J. Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 34 (2003) 2502-2507
28. Claesson L., Gosman-Hedstrom G., Johannesson M., Fagerberg B., and Blomstrand C. Resource utilization and costs of stroke unit care integrated in a care continuum: a 1-year controlled, prospective, randomized study in elderly patients: the Goteborg 70+ stroke study. Stroke 31 (2000) 2569-2577
29. Anderson C., Mhurchu C.N., Rubenach S., Clark M., Spencer C., and Winsor A. Home or hospital for stroke rehabilitation? Results of a randomized controlled trial II: cost minimization analysis at 6 months. Stroke 31 (2000) 1032-1037
30. National Collaborating Centre for Chronic Conditions. Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA) (2008), Royal College of Physicians, London